Organic compounds -- part of the class 532-570 series – Organic compounds – Phosphorus esters
Reexamination Certificate
2006-09-12
2006-09-12
Solola, Taofiq (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Phosphorus esters
Reexamination Certificate
active
07105695
ABSTRACT:
The original synthesis of combretastatin A-2 (1a) was modified to provide an efficient scale-up procedure for obtaining this antineoplastic stilbene. Subsequent conversion to a useful prodrug was accomplished by phosphorylation employing in situ formation of dibenzylchlorophosphite followed by cleavage of the benzyl ester protective groups with bromotrimethylsilane to afford phosphoric acid intermediate 11. The latter was immediately treated with sodium methoxide to complete a practical route to the disodium phosphate prodrug (2a). The phosphoric acid precursor (11) of phosphate 2a was employed in a parallel series of reactions to produce a selection of metal and ammonium cation prodrug candidates. Each of the phosphate salts (2a–q) was evaluated with respect to relative solubility behavior, cancer cell growth inhibition, and antimicrobial activity.
REFERENCES:
patent: WO 99/35150 (1999-07-01), None
patent: WO 02/006279 (2002-01-01), None
Moser Bryan R.
Pettit George R.
Arizona Board of Regents, acting for and on behalf of Arizona St
Solola Taofiq
LandOfFree
Synthesis of combretastatin A-2 prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis of combretastatin A-2 prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of combretastatin A-2 prodrugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3586898